Figure 3From: Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancersDistant disease-free survival of immunohistochemically CK5/14-negative and CK5/14-positive tumors in the whole data set. The basal cytokeratin-positive tumors show significantly shorter survival during the first years of the follow-up, but this difference is lost with time.Back to article page